Prevention & lipidsCohort study

Combining Genomics With Lipid and Inflammatory Biomarkers to Predict Coronary Artery Disease Risk

J Am Coll CardiolPublished

  • Prospective cohort study

Authors' conclusion

CAD PRS, LDL-C, hsCRP, and Lp(a) show independent age- and sex-specific associations with CAD.

Study context

Population
UK Biobank participants aged 40 to 69 years with baseline coronary artery disease (CAD) polygenic risk score (PRS), low-density-lipoprotein cholesterol (LDL-C), Lp(a) and high-sensitivity C-reactive protein (hsCRP) values
Participants
215,695 participants
Exposure
CAD PRS, LDL-C, Lp and hsCRP vs pooled cohort equations
Outcome
Incident CAD
Follow-up
12-year follow-up

Main finding

As reported in the abstract

Incident CAD per biomarker elevation
Hazard ratio (95% CI)
CAD PRS
1.79(1.70–1.89)
LDL-C
1.60(1.48–1.66)
Lp(a)
1.20(1.12–1.29)
hsCRP
1.64(1.57–1.72)

Per biomarker elevation, as printed

Incident CAD, men
4,721
Incident CAD, women
2,425
All biomarkers elevated vs none elevated: fold increased risk of CAD
4.65

Observational data: associations, not effects.

Further findings

OutcomeHR per SD (95% CI)
CAD PRS by sex (HR per SD) — CAD PRS, men1.49 (1.45–1.54)
CAD PRS by sex (HR per SD) — CAD PRS, women1.37 (1.31–1.44)
  • CAD PRS by sex (HR per SD): P-interaction ≤ 0.001

Biomarker HRs by age

All biomarkers conferred greater HRs at younger ages
P < 0.0001

Discrimination and reclassification

C-statistic, combined 4-biomarker model
0.753
C-statistic, pooled cohort equations
0.740
Continuous net reclassification index, 4-biomarker model vs pooled cohort equations
32.0%
C-statistic of 4-biomarker model higher in younger individuals in both sexes

Original publication

Combining Genomics With Lipid and Inflammatory Biomarkers to Predict Coronary Artery Disease Risk. J Am Coll Cardiol. Published 18 March 2026. doi:10.1016/j.jacc.2026.01.076

Summarised from the published abstract; every number is checked against it